|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 762.63 USD | +3.29% |
|
+16.25% | -1.20% |
| Market Cap | 76.15B 66.2B 61.62B 56.57B 107B 7,270B 108B 726B 285B 3,619B 286B 280B 12,135B | P/E 2026 * |
18.1x | P/E 2027 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise Value | 69.28B 60.23B 56.06B 51.47B 97.2B 6,614B 98.7B 661B 259B 3,293B 260B 254B 11,041B | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 3.58x |
| Free-Float |
73.31% | Yield 2026 * |
0.51% | Yield 2027 * | 0.58% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.49% | ||
| 1 week | +16.25% | ||
| 1 month | +22.31% | ||
| 3 months | +7.86% | ||
| 6 months | +2.86% | ||
| Current year | -1.20% |
| 1 week | 659.53 |  | 764.75 |
| 1 month | 625.7 | | 764.75 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/7/26 | Sell | Director | -200 | 0.0002% | ||
| 19/2/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 9/2/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | +16.25% | +39.81% | +2.79% | 76.15B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 47.83B | |
| +2.72% | -9.39% | +17.04% | +176.83% | 48.89B | |
| -3.81% | +7.74% | -54.57% | -54.17% | 41.37B | |
| -2.40% | +0.38% | +58.55% | -24.89% | 29.99B | |
| -2.82% | +1.57% | +59.59% | +87.57% | 24.23B | |
| -5.35% | +1.39% | +85.45% | -53.41% | 21.75B | |
| -1.59% | -3.61% | -11.53% | +150.58% | 19.25B | |
| -0.42% | +2.89% | +74.55% | +128.45% | 17.14B | |
| -2.50% | -4.68% | +69.43% | +128.76% | 15.66B | |
| Average | -1.94% | +0.87% | +38.68% | +59.10% | 34.22B | |
| Weighted average by Cap. | -1.54% | +2.63% | +32.51% | +47.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.9B 14.69B 13.68B 12.56B 23.71B 1,613B 24.08B 161B 63.26B 803B 63.47B 62.08B 2,693B | 18.31B 15.92B 14.82B 13.6B 25.69B 1,748B 26.09B 175B 68.54B 870B 68.77B 67.26B 2,918B |
| Net income | 4.61B 4B 3.73B 3.42B 6.46B 440B 6.56B 43.93B 17.24B 219B 17.3B 16.92B 734B | 5.35B 4.65B 4.33B 3.98B 7.51B 511B 7.63B 51.05B 20.04B 254B 20.1B 19.66B 853B |
| Net Debt | -6.87B -5.97B -5.56B -5.1B -9.64B -656B -9.78B -65.51B -25.71B -326B -25.79B -25.23B -1,095B | -10.55B -9.17B -8.54B -7.84B -14.81B -1,007B -15.03B -101B -39.51B -502B -39.64B -38.77B -1,682B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | USD 762.63 | +3.29% | 1,158,583 |
| 30/07/26 | USD 738.34 | +6.17% | 1,460,963 |
| 29/07/26 | USD 695.42 | +0.03% | 1,022,421 |
| 28/07/26 | USD 695.18 | +4.20% | 900,408 |
| 27/07/26 | USD 667.17 | +1.70% | 650,984 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
